Overview
Steven Larmon is a Hematologist Oncology specialist and a Hematologist in Keene, New Hampshire. Dr. Larmon is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Baystate Medical Practices Inc
John Mccann is a Hematologist and a Hematologist Oncology provider in Springfield, Massachusetts. Dr. Mccann is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC). Dr. Mccann is currently accepting new patients.
Dartmouth-Hitchcock Clinic
Tyler Curiel is an Oncologist and an Infectious Disease provider in Lebanon, New Hampshire. Dr. Curiel has been practicing medicine for over 44 years and is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Melanoma, Ovarian Cancer, and Bladder Cancer. Dr. Curiel is currently accepting new patients.
Berkshire Faculty Services Inc
Sean Mullally is a Hematologist Oncology specialist and a Hematologist in Pittsfield, Massachusetts. Dr. Mullally is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, and Familial Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Larmon isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung AdenocarcinomaDr. Larmon isDistinguished. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Larmon isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Larmon isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Chronic Lymphocytic Leukemia (CLL)
- EGFR Positive Lung CancerDr. Larmon isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Prostate CancerDr. Larmon isAdvanced. Learn about Familial Prostate Cancer.
- Inflammatory Breast CancerDr. Larmon isAdvanced. Learn about Inflammatory Breast Cancer.
- Large-Cell Lung CarcinomaDr. Larmon isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Multiple MyelomaDr. Larmon isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Adult Immune ThrombocytopeniaDr. Larmon isExperienced. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Larmon isExperienced. Learn about Anemia.
- AngiosarcomaDr. Larmon isExperienced. Learn about Angiosarcoma.
- Bladder CancerDr. Larmon isExperienced. Learn about Bladder Cancer.
- Blood ClotsDr. Larmon isExperienced. Learn about Blood Clots.
- Breast CancerDr. Larmon isExperienced. Learn about Breast Cancer.